Cases & Deals

Axion BioSystems issues Common Stock in Regulation D Rule 506 offering

Clients Axion Biosystems, Inc.

Jones Day represented Axion BioSystems, Inc., a privately held bio-tech start up company, in connection with its issuance of $3.2 million of Common Stock in a Regulation D Rule 506 offering.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.